The Greenrose Holding Company Inc. is a multi-state cannabis holding company engaged in the cultivation, processing, manufacturing, and wholesale distribution of regulated medical and adult-use cannabis products. The company's product portfolio comprises premium cured cannabis flower; strain-specific pre-rolled joints; vaporizers, all-in-one disposable vape pens, and vape cartridges utilizing advanced heating hardware; concentrated cannabis extracts, including distillate oils, live resin, shatter, and wax; ingestible cannabis formulations and edibles; cannabis-infused topicals; and bulk biomass for commercial processors. Greenrose provides end-to-end supply chain and operational services across limited-license state markets, including climate-controlled indoor and greenhouse cultivation; supercritical fluid, hydrocarbon, and ethanol botanical extractions; precision oil formulation and automated cartridge filling; packaging and labeling compliance; and secure wholesale transportation to licensed retail dispensaries. Founded in 2014 and formerly known as Greenrose Acquisition Corp. prior to its corporate restructuring and rebranding in November 2021, the company is headquartered in Amityville, New York. In major recent developments, the company pursued multi-state expansion through the acquisitions of Connecticut-licensed producer Theraplant, LLC and Arizona-based operator True Harvest, LLC. Following subsequent capital constraints and debt service defaults, Greenrose entered into strict foreclosure agreements with senior secured lenders, resulting in the surrender and transfer of its primary operational assets and subsidiary holdings. On June 18, 2024, The Greenrose Holding Company Inc. filed a voluntary petition for Chapter 7 liquidation under the United States Bankruptcy Code in the U.S. Bankruptcy Court for the Eastern District of New York, leading to the reclassification and trading of its common equity under the ticker symbol GNRSQ on the OTC Expert Market.